NovoCare vs Eden

There is no version of this comparison where buying branded Wegovy from Eden makes financial sense, and the point of the page is to show the arithmetic rather than assert it.

NovoCare is Novo Nordisk's own self-pay pharmacy. Wegovy tablets at 1.5 mg and 4 mg are $149 a month. Injections are $199 at 0.25 mg and 0.5 mg, $349 at the 1 mg to 2.4 mg maintenance doses, and $399 at 7.2 mg. No membership, no prior authorisation, free shipping.

Eden resells the same manufacturer's same product at $1,695 a month, medication only, on top of a mandatory membership at $39 for the first month and $99 after — about $1,794 from month two.

What the difference buys

Nothing, in the product. It is the same Wegovy, made by the same company, with the same manufacturer-controlled quality. The markup is roughly $1,545 a month, or $18,540 a year.

The comparison Eden wants you to make, and the one you should

Eden's framing is its own compounded semaglutide at about $198 all-in against its branded Wegovy at $1,794 — which makes compounded look like an obvious bargain. That comparison is constructed.

The comparison that matters is Eden's compounded semaglutide at $198 against NovoCare's branded Wegovy tablets at $149. An FDA-approved product, direct from the manufacturer, for less than the compounded copy with its membership attached.

NovoCare's genuine limitation

It dispenses and nothing else. No consultation, no monitoring, no dose adjustment. You need a prescription from a clinician elsewhere — a primary care physician, or a service like QuickMD at $99 a consultation, or Sesame which matches the $149 pill price with a consultation included.

Eden does prescribe in-house, and carries compounded options NovoCare does not. Those are real reasons to use Eden. Its branded pricing is not one of them.